We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multipurpose Biosensors Rely on Luciferase to Light up Target Molecules

By LabMedica International staff writers
Posted on 05 Aug 2015
A team of Swiss molecular biologists developed a luminescent marker system that sends out a light signal after binding to a specific target molecule.

Investigators at Ecole Polytechnique Fédérale de Lausanne (Switzerland) attached a small chemical tag to the enzyme luciferase, which catalyzes the light produced by fireflies. More...
The tag molecule prevented luciferase from producing light, but when the tag detected its target protein, it released luciferase and attached to that protein instead. As a result, luciferase was free to emit a light, which was the signal that the target molecule had been found.

As proof-of-principle the investigators described in the July 22, 2015, online edition of the journal Nature Communications a luciferase controlled by human carbonic anhydrase whose activity could be controlled by proteins or small molecules in vitro and on living cells, and novel fluorescent and bioluminescent biosensors.

"You can think of the tagged luciferase as a cyborg molecule," said senior author Dr. Kai Johnsson, professor of chemistry at Ecole Polytechnique Fédérale de Lausanne. "Half bio, half synthetic. How could you make luciferase sensitive to the presence of another protein just through mutations? It is a lot of work. With this chemical trick, all we have to worry about is designing an appropriate tag that can recognize the target protein. This is a generalized design. It shows how you can exploit synthetic chemistry to create sophisticated biosensor proteins."

Related Links:
Ecole Polytechnique Fédérale de Lausanne



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.